User:Letícia Oliveira Rojas Cruz/Sandbox 1

From Proteopedia

< User:Letícia Oliveira Rojas Cruz(Difference between revisions)
Jump to: navigation, search
Current revision (22:04, 9 July 2025) (edit) (undo)
 
(15 intermediate revisions not shown.)
Line 1: Line 1:
-
==Introduction==
+
==Angiotensin-converting enzyme 2 (ACE2) - (PDB 1R42)==
-
<StructureSection load='6m17' size='330' side='right' caption='PDB 6m17' scene=''>
+
<StructureSection load='6m17' size='425' side='right' caption='PDB 6m17' scene='10/1083732/Ace2_completa/3'>
-
<scene name='10/1083732/Ace2_completa/3'>Angiotensin-converting enzyme 2 (ACE2)</scene> is an important protein expressed in several human tissues, such as the heart and kidneys. It plays a key role in the Renin-Angiotensin System - "RAS" - by catalyzing the conversion of angiotensin II (Ang II), promoting blood pressure regulation.
+
<scene name='10/1083732/Ace2_completa/3'>Angiotensin-converting enzyme 2 (ACE2)</scene> is an important protein expressed in several human tissues, such as the heart and kidneys. It plays a key role in the Renin-Angiotensin-Aldosterone System - "RAAS" - by catalyzing the conversion of angiotensin II (Ang II), promoting blood pressure regulation.
-
Another function of ACE2 is related to SARS-CoV-2 infection, the virus responsible for the COVID-19 pandemic. In this context, ACE2 serves as the entry receptor for the virus.
+
Another function of ACE2 is related to SARS-CoV-2 infection, the virus responsible for the COVID-19 pandemic. In this context, ACE2 serves as the entry receptor for the virus. <ref>PMID:33389262</ref>
 +
 
 +
[[Image:Protein ACE2 PDB 1r42.png|225px|right|thumb|Protein ACE2, [[1r42]]]]
== General structure information ==
== General structure information ==
Line 18: Line 20:
== Physiological Function ==
== Physiological Function ==
-
<scene name='10/1083732/Ace2_completa/3'>ACE2</scene> is a transmembrane glycoprotein that has an extracellular catalytic domain. It is classified as a hydrolase, more specifically a carboxypeptidase-type peptidase, responsible for the cleavage of peptide bonds at the C-terminal site.
+
<scene name='10/1083732/Ace2_completa/3'>ACE2</scene> is a transmembrane glycoprotein that has an extracellular catalytic domain. It is classified as a hydrolase, more specifically a carboxypeptidase-type peptidase, responsible for the cleavage of peptide bonds at the C-terminal site. <ref>PMID:17897633</ref>
The ACE2 acts to cleave a single C-terminal residue of some substrates. One of those substrates is Angiotensin II (Ang II), which is degrated into Angiotensin-(1-7); to a lesser extent, Angiotensin I (Ang I) is also a substrate, turning in into Angiotensin-(1-9).
The ACE2 acts to cleave a single C-terminal residue of some substrates. One of those substrates is Angiotensin II (Ang II), which is degrated into Angiotensin-(1-7); to a lesser extent, Angiotensin I (Ang I) is also a substrate, turning in into Angiotensin-(1-9).
-
The Renin-Angiotensin System - "RAS" -, in which ACE2 acts, is an important signaling pathway responsible for vascular homeostasis.
+
The Renin-Angiotensin-Aldosterone System - "RAAS" -, in which ACE2 acts, is an important signaling pathway responsible for vascular homeostasis.
-
In general, Ang II, generated by the action of ACE on Ang I, and this one by the action of Renin on Angiotensinogen, acts on AT1 and AT2 receptors. Its main action is vasoconstriction (by AT1 receptor), increasing blood pressure. On the other hand, Angiotensin (1-7), generated from Ang II by ACE2, has the opposite function, leading to a decline in blood pressure through vasodilation and release of Nitric Oxide (NO) through its action on the MAS oncogene receptor, antagonizing the actions of Ang II.
+
In general, Ang II, generated by the action of ACE on Ang I, and this one by the action of Renin on Angiotensinogen, acts on AT1 and AT2 receptors. Its main action is vasoconstriction (by AT1 receptor), increasing blood pressure. On the other hand, Angiotensin (1-7), generated from Ang II by ACE2, has the opposite function, leading to a decline in blood pressure through vasodilation and release of Nitric Oxide (NO) through its action on the MAS oncogene receptor, antagonizing the actions of Ang II. <ref>PMID:19461648</ref>
 +
 
 +
[[Image:RAAS.png|350px]] <ref>PMID:33389262</ref>
== Pathological Relevance ==
== Pathological Relevance ==
The ACE2 protein became better known and widely publicized in 2020 due to its role in the infection by '''SARS-CoV-2''', the virus responsible for the Covid-19 pandemic.
The ACE2 protein became better known and widely publicized in 2020 due to its role in the infection by '''SARS-CoV-2''', the virus responsible for the Covid-19 pandemic.
-
In this disease, ACE2 acts as a viral receptor, to which the Spike (S) viral protein binds, promoting the entry of the virus into the host cell. The specific region of the S protein responsible for binding to the ACE2 receptor is called '''receptor-binding domain (RBD)''', and is located in the S1 subunit of the Spike protein.
+
In this disease, ACE2 acts as a viral receptor, to which the Spike (S) viral protein binds, promoting the entry of the virus into the host cell. The specific region of the S protein responsible for binding to the ACE2 receptor is called '''receptor-binding domain (RBD)''', and is located in the S1 subunit of the Spike protein. <ref>PMID:32142651</ref>
-
== Structure highlights ==
+
== Structure highlights<ref>PMID:32132184</ref>==
=== ACE2-B0AT1 Complex ===
=== ACE2-B0AT1 Complex ===
'''''Association with B0AT1'''''
'''''Association with B0AT1'''''
-
The ACE2 protein can associate with the neutral amino acid transporter <scene name='10/1078774/B0at1_zoom2/1'>B0AT1</scene>, also known as SLC6A19. In this context, ACE2 first forms a <scene name='10/1083732/Dimer_ace2_final/1'>homodimer</scene>, where two ACE2 molecules interact side by side. Each ACE2 monomer then binds to one B0AT1 molecule. This results in a complex composed of '''{{Font color|darkviolet|two ACE2}}''' and '''{{Font color|salmon|two B0AT1}}''' molecules, which is commonly described as a <scene name='10/1083732/Ace2_and_b0at1/1'>dimer of heterodimers</scene>. This association is essential for the transport of neutral amino acids in intestinal cells and the anchoring of ACE2 in the cell membrane, keeping the catalytic site facing the extracellular environment. Although ACE2 dimerization occurs independently of B0AT1, the transporter plays a stabilizing role by interacting with the Collectrin-like Domain.
+
The ACE2 protein can associate with the neutral amino acid transporter <scene name='10/1078774/B0at1_zoom2/1'>B0AT1</scene>, also known as SLC6A19. In this context, ACE2 first forms a <scene name='10/1083732/Dimer_ace2_final/2'>homodimer</scene>, where two ACE2 molecules interact side by side. Each ACE2 monomer then binds to one B0AT1 molecule. This results in a complex composed of '''{{Font color|darkviolet|two ACE2}}''' and '''{{Font color|salmon|two B0AT1}}''' molecules, which is commonly described as a <scene name='10/1083732/Ace2_and_b0at1/2'>dimer of heterodimers</scene>. This association is essential for the transport of neutral amino acids in intestinal cells and the anchoring of ACE2 in the cell membrane, keeping the catalytic site facing the extracellular environment. Although ACE2 dimerization occurs independently of B0AT1, the transporter plays a stabilizing role by interacting with the Collectrin-like Domain.
-
This ACE2-B0AT1 complex is anchored to the cell plasma membrane, keeping the ACE2 protein in an extracellular environment. The intermembrane region has apolar characteristics, since it must interact with the hydrophobic tails of the phospholipids. Analyzing the <scene name='10/1083732/Polaridade_2/1'>polarity</scene> of the complex, an '''{{Font color|gray|apolar region}}''' is observed in the B0AT1 region, showing that it is in this region where the complex is in contact with the plasma membrane. The '''{{Font color|orchid|polar regions}}''' (CLD and PD domains of ACE2) are located in the external region, without contact with the apolar region of the phospholipids.
+
This ACE2-B0AT1 complex is anchored to the cell plasma membrane, keeping the ACE2 protein in an extracellular environment. The intermembrane region has apolar characteristics, since it must interact with the hydrophobic tails of the phospholipids. Analyzing the <scene name='10/1083732/Polaridade_2/2'>polarity</scene> of the complex, an '''{{Font color|gray|apolar region}}''' is observed in the B0AT1 region, showing that it is in this region where the complex is in contact with the plasma membrane. The '''{{Font color|orchid|polar regions}}''' (CLD and PD domains of ACE2) are located in the external region, without contact with the apolar region of the phospholipids.
=== ACE2 Dimerization ===
=== ACE2 Dimerization ===
Line 42: Line 46:
In this region, there is an extensive network of polar interactions that stabilizes the ACE2 dimer. The most actively involved amino acid residues are between 636 and 658 and between 708 and 717, corresponding to the second and fourth helices of the CLD domain, respectively.
In this region, there is an extensive network of polar interactions that stabilizes the ACE2 dimer. The most actively involved amino acid residues are between 636 and 658 and between 708 and 717, corresponding to the second and fourth helices of the CLD domain, respectively.
-
<scene name='10/1078774/Interacao_cation/1'>Polar cation-pi interactions</scene> occur between the amino acids '''{{Font color|turquoise|Arg652}}''' and '''{{Font color|slateblue|Tyr641}}''' of the opposite ACE2 molecule, and between '''{{Font color|turquoise|Arg710}}''' and '''{{Font color|slateblue|Tyr633}}'''. Additionally, <scene name='10/1078774/Lig_hidrogenio/1'>hydrogen bonds</scene> help stabilize the dimer interface: Arg652 forms a hydrogen bond with Asn638, which further interacts with Gln653, linked to Asn636. Also, Arg710 forms a hydrogen bond with Glu639, and Arg716 connects with Ser709 and Asp713.
+
<scene name='10/1078774/Interacao_cation/2'>Polar cation-pi interactions</scene> occur between the amino acids '''{{Font color|slateblue|Arg652}}''' and '''{{Font color|turquoise|Tyr641}}''' of the opposite ACE2 molecule, and between '''{{Font color|slateblue|Arg710}}''' and '''{{Font color|turquoise|Tyr633}}'''. Additionally, <scene name='10/1078774/Lig_hidrogenio/1'>hydrogen bonds</scene> help stabilize the dimer interface: '''{{Font color|slateblue|Arg652}}''' forms a hydrogen bond with '''{{Font color|slateblue|Arg638}}''', which further interacts with '''{{Font color|slateblue|Gln653}}''', linked to '''{{Font color|turquoise|Asn636}}'''. Also, '''{{Font color|slateblue|Arg710}}''' forms a hydrogen bond with '''{{Font color|turquoise|Asn639}}''', and '''{{Font color|turquoise|Arg716}}''' connects with '''{{Font color|slateblue|Ser709}}''' and '''{{Font color|slateblue|Asp713}}'''.
'''''Domain PD Interation'''''
'''''Domain PD Interation'''''
-
In addition to the CLD, the Peptidase Domain (PD) also contributes to ACE2 dimerization. The amino acids Cys133, Asn134, Asp136, Asn137, Gln139, Glu140, and Cys141 form a <scene name='10/1078774/Lig_hidrogenio/2'>loop</scene> region within the PD. The two cysteines (Cys133 and Cys141) establish a disulfide bond, which stabilizes the loop conformation, supported by additional intraloop polar interactions. Furthermore, Gln139 forms a polar interaction with Gln175 from the other ACE2 monomer.
+
In addition to the CLD, the Peptidase Domain (PD) also contributes to ACE2 dimerization. The amino acids '''{{Font color|slateblue|Cys133}}''', '''{{Font color|slateblue|Asn134}}''', '''{{Font color|slateblue|Asp136}}''', '''{{Font color|slateblue|Asn137}}''', '''{{Font color|slateblue|Gln139}}''', '''{{Font color|slateblue|Glu140}}''', and '''{{Font color|slateblue|Cys141}}''' form a <scene name='10/1083732/Loop_pd/2'>loop</scene> region within the PD. The two cysteines ('''{{Font color|slateblue|Cys133}}''' and '''{{Font color|slateblue|Cys141}}''') establish a disulfide bond, which stabilizes the loop conformation, supported by additional intraloop polar interactions. Furthermore, '''{{Font color|slateblue|Gln139}}''' forms a polar interaction with '''{{Font color|turquoise|Gln175}}''' from the other ACE2 monomer.
=== SARS-CoV-2 Binding ===
=== SARS-CoV-2 Binding ===
-
'''{{Font color|crimson|ACE2}}''' <scene name='10/1083732/Sars_cov_2/1'>binds</scene> to the '''{{Font color|darkmagenta|Spike (S)}}''' glycoprotein of the SARS-CoV-2 virus, promoting its internalization into the cell. More specifically, binding occurs between the PD subunit of ACE2 and the receptor binding domain (RBD) of the S1 subunit of the S protein. Each PD binds to an RBD by polar bonds, with one ACE2 dimer accommodating two S protein trimers.
+
'''{{Font color|crimson|ACE2}}''' <scene name='10/1083732/Sars_cov_2/2'>binds</scene> to the '''{{Font color|darkmagenta|Spike (S)}}''' glycoprotein of the SARS-CoV-2 virus, promoting its internalization into the cell. More specifically, binding occurs between the PD subunit of ACE2 and the receptor binding domain (RBD) of the S1 subunit of the S protein. Each PD binds to an RBD by polar bonds, with one ACE2 dimer accommodating two S protein trimers.
 +
</StructureSection>
== References ==
== References ==
<references/>
<references/>
 +
 +
 +
OUDIT, G. Y. et al. Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic. Cell, v. 186, n. 5, p. 906–922, mar. 2023.

Current revision

Angiotensin-converting enzyme 2 (ACE2) - (PDB 1R42)

PDB 6m17

Drag the structure with the mouse to rotate

References

  1. Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021 May;40(5):905-919. PMID:33389262 doi:10.1007/s10096-020-04138-6
  2. Lambert DW, Hooper NM, Turner AJ. Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system. Biochem Pharmacol. 2008 Feb 15;75(4):781-6. PMID:17897633 doi:10.1016/j.bcp.2007.08.012
  3. Iwai M, Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res. 2009 Jul;32(7):533-6. PMID:19461648 doi:10.1038/hr.2009.74
  4. Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021 May;40(5):905-919. PMID:33389262 doi:10.1007/s10096-020-04138-6
  5. Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten C, Pohlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020, Mar 5. PMID:32142651 doi:http://dx.doi.org/10.1016/j.cell.2020.02.052
  6. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar 4. pii: science.abb2762. doi: 10.1126/science.abb2762. PMID:32132184 doi:http://dx.doi.org/10.1126/science.abb2762


OUDIT, G. Y. et al. Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic. Cell, v. 186, n. 5, p. 906–922, mar. 2023.

Proteopedia Page Contributors and Editors (what is this?)

Letícia Oliveira Rojas Cruz

Personal tools